Rapamune 1 MG/ML oral solution
( DrugBank: - / KEGG DRUG: - )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
137 | Focal cortical dysplasia | 1 |
158 | Tuberous sclerosis | 2 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
280 | Huge arteriovenous malformation with cervicofacial or limb lesion | 1 |
137. Focal cortical dysplasia
Clinical trials : 14 / Drugs : 10 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathways : 49
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
158. Tuberous sclerosis
Clinical trials : 129 / Drugs : 56 - (DrugBank : 20) / Drug target genes : 35 - Drug target pathways : 116
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
280. Huge arteriovenous malformation with cervicofacial or limb lesion
Clinical trials : 29 / Drugs : 31 - (DrugBank : 15) / Drug target genes : 12 - Drug target pathways : 163
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|